Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-365P** (RNA, U6 small nuclear 365, pseudogene) is a pseudogene related to U6 small nuclear RNA, mapping to human chromosome 1[4]. U6 snRNA belongs to a family of small nuclear non-coding RNAs that play a key role in pre-mRNA splicing, forming a core part of the spliceosome complex[3][5]. However, as a **pseudogene**, RNU6-365P is not believed to produce a functional RNA or protein; it lacks coding potential and regulatory elements necessary for normal gene function[1][2]. Pseudogenes typically arise from duplication or retrotransposition events and accumulate mutations that inactivate their function[2]. While some pseudogenes can have regulatory or disease-modifying effects, there is no evidence that RNU6-365P performs any biological roles or serves as a therapeutic target. **Is_incorrect?** - Yes. The designation "RNA, U6 small nuclear 365, pseudogene" refers to a non-coding RNA pseudogene, not a targetable macromolecule like an enzyme, receptor, transporter, or signaling protein. It is not considered a conventional drug target, and there is no evidence of it being involved in pharmacology, clinical biomarkers, or therapeutic modulation. Some pseudogenes have emerging regulatory roles or may serve as disease biomarkers, but there is no data supporting such functions for RNU6-365P[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 365, pseudogene (RNU6-365P).